Cisplatin, hyperthermia and radiation treatment in human cisplatin-sensitive and resistant glioma cell lines

International Journal of Hyperthermia

Volumn 12, Issue 6, 1996, Pages 801-812

  Raaphorst, G P ^a   Yang, H ^a   Wilkins, D E ^a   Ng, C E ^a  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

Cisplatin; Glioma cells; Long duration mild hyperthermia; Low dose rate irradiation

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; CISPLATIN;

ARTICLE; CANCER RADIOTHERAPY; CELL KILLING; GLIOMA CELL; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; TUMOR CELL LINE;

EID: 0029850749     PISSN: 02656736     EISSN: None     Source Type: Journal    
DOI: 10.3109/02656739609027686     Document Type: Article

References (69)

1. AMICHETTI, M., GRAIFF, C., FELLIN, G., PANI, G., BOLONER, A., MALUTA, S., and VALDAGNI, R., 1993, Cisplatin hyperthermia and radiation (trimodal therapy) in patients with locally advanced head and neck tumours: a phase I-II study. Radiation Oncology, 26, 801-807.
2. BEGG, A. C., VAN DER KOLK, P. J., DEWIT, L., and BARTELINK, H., 1986, Radiosensitization by cisplatin of RIF1 tumour cells in vitro. International Journal of Radiation Oncology, 50, 871-884.
3. BEGG, A. C., STEWART, F. A., DEWIT, L., and BARTELINK, H., 1990, Interactions between cisplatin and radiation in experimental rodent tumours and normal tissues. Antitumour drug-radiation interactions edited by B. T. Hill and A. S. Bellamy (Boca Raton, FL: CRC Press) pp. 153-170.
4. BEN HUR, E., ELKIND, M. M., and BRONK, B. V., 1974, Thermally enhanced radioresponses of cultured Chinese hamster cells (Inhibition of repair of sublethal damage and enhancement of lethal damage). Radiation Research, 58, 38-51.
5. BOSSCHA, H. T., TIMMER, A., MEIJER, C., DEVRIES, E. G. E., DE JONG, B., OOSTERHUIS, J. W., and MULDER, H., 1993, Cis-diaminedichloroplatin (II) resistance in vitro and in vivo in human embryonal carcinoma cells. Cancer Research, 53, 5707-5713.
6. BOWDEN, G. T., KASUNIC, M., and SIM, D., 1983, Sequence dependence for the hyperthermic potentiation of cis-diaminedichloroplatinum (II) induced cytotoxicity and DNA damage. Proceedings of the Third North American Hyperthermia Group, pp. 161-162.
7. BRITTEN, R. A., WARENIUS, H. M., CARRAWAY, A. V., and MURRAY, D., 1994, Differential modulation of radiosensitivity following induction of cisplatin resistance in radiation-sensitive and radiation-resistant human tumour cells. Radiation Oncology Investigations, 2, 25-31.
8. CANON, J. L., HUMBLET, Y., and SYMANN, M., 1990, Resistance to cisplatin: how to deal with the problem? European Journal of Cancer, 26, 1-3.
9. CARDE, P., and LAVAL, F., 1981, Effect of cis-dichlorodiamine platinum II and X-rays on mammalian cell survival. International Journal of Radiation Oncology, 7, 929-933.
10. COUGHLIN, C. T., and RICHMOND, R. C., 1985, Platinum based combined modality approach for locally advanced head and neck carcinoma. International Journal of Radiation Oncology, 115, 915-919.
11. DA SILVA, V., GUTIN, P. H., HOFF, M. H. B., BERNSTEIN, M. A., DEEN, D. F., and WEAVER, K. A., 1984, The effect of combination treatment with cisplatin and low dose-rate 125 I radiation in a murine brachytherapy model. International Journal of Radiation Oncology, 10, 1471-1472.
12. DA SILVA, V. F., RAAPHORST, G. P., GOYAL, R., and FEELEY, M. M., 1987, Drug cytotoxicity at elevated temperature. Journal of Neurosurgery, 67, 83-88.
13. DEWIT, L., BARTELINK, H., and RUMKE, P. H., 1985, Concurrent cis-diaminedichloroplatinum (II) and radiation treatment for melanoma metastases: a pilot study. Radiotherapeutic Oncology, 3, 303-309.
14. DEWIT, L., 1987, Combined treatment of radiation and cis-diaminedichloroplatinum (II): A review of experimental and clinical data. International Journal of Radiation Oncology, 13, 403-426.
15. DIKOMEY, E., and JUNG, H., 1988, Correlation between polymerase β activity and thermal radiosensitization in Chinese hamster ovary cells. Recent Results in Cancer Research, 109, 35-41.
16. DIKOMEY, E., and JUNG, H., 1993, Correlation between thermal radiosensitization and heat-induced loss of DNA polymerase β activity in CHO cells. International Journal of Radiation Biology, 2, 215-221.
17. DOUPLE, E. B., 1990, Interaction between cisplatin coordination complexes and radiation. Antitumour drug-radiation interactions. Edited by B. T. Hill and A. S. Bellamy (Boca Raton, FL: CRC Press). pp. 171-190.
18. DOUPLE, E. B., WILLS, M. L., and JONES, E., 1991, Radiopotentiation in a murine tumour (MTG-B) by continuous infusion platinum. Concomitant Continuous infusion Chemotherapy and Radiation (New York: Springer-Verlag) pp. 191-196.
19. DRITSCHILO, A., PIRO, A., and KELMAN, A. D., 1979, The effect of cisplatinum on the repair of radiation damage in plateau phase Chinese hamster V79 cells. International Journal of Radiation Oncology, 5, 1345-1349.
20. EASTMAN, A., and SCHULTE, N., 1988, Enhanced DNA repair as a mechanism of resistance to cis-diaminedichloroplatinum (II). Biochemistry, 27, 4730-4734.
21. ENGELHARDT, R., 1987, Hyperthermia and drugs. Recent Results in Cancer Research, 104, 136-203.
22. FU, K. K., RAYNER, P. A., and LAM, K. N., 1984, Modification of the effects of continuous low dose-rate irradiation by concurrent chemotherapy infusion. International Journal of Radiation Oncology, 10, 1431-1478.
23. FU, K. K., LAM, K. N., and RAYNER, P. A., 1985, The influence of time sequence of cisplatin administration and continuous low dose-rate irradiation (LDRI) on their combined effects on murine squamous cell carcinoma. International Journal of Radiation Oncology, 11, 2119-2124.
24. FU, K. K., LAM, K. N., and RAYNER, P. A., 1986, Effects of continuous low dose-rate irradiation and concurrent infusion of mitomycin, cisplatin and 5 Flourouracil on three murine tumours. Endocurietherapy/Hyperthermic Oncology, 2, 157-162.
25. FUJII, R., MUTAK, M., NIWA, K., YAMADA, K., AIBOU, T., NAKAGAWA, M., KUWANO, M., and AKIYAMA, S., 1994, Active efflux for cisplatin in cisplatin-resistant human KB cells. Japanese Journal of Cancer Research, 85, 426-433.
26. GERNER, E. W. (ed.), 1992, Proceedings of the 6th Congress on Hyperthermic One. (Vol. I and II). Arizona Board of Regents, Tucson, Arizona.
27. HAHN, G. M., 1979, Potentiation of therapy drugs and hyperthermia. Cancer Research, 39, 2264-2268.
28. HALL, E. J., 1994, Radiobiology for the Radiologist (Philadelphia: J. B. Lippincott) pp. 107-132.
29. HERMAN, T. S., SWEETS, C. C., WHITE, D. M., and GERNER, E. W., 1982, Effect of rate of heating on lethality due to hyperthermia and selected chemotherapy drugs. Journal of the National Cancer Institute, 68, 487-492.
30. HERMAN, T. S., and TEICHER, B. A., 1988, Sequencing of trimodality therapy. (cisdiaminedichloroplatinum/hyperthermia/radiation) as determined by tumour growth delay and tumour cell survival in the FSa II C fibrosarcoma. Cancer Research, 48, 2693-2697.
31. IRELAND, C. M., PITTMAN, S. M., JONES, S. L., and HARNETT, P. R., 1994, Establishment of an in vitro model for cisplatin resistance in human neuroblastoma cell lines. Anticancer Research, 14, 2397-2404.
32. JEKUNEN, A. P., HOM, D. K., ALCARAZ, J. E., EASTMAN, A., and HOWELL, S. B., 1994, Cellular pharmacology of dichloro(ethylenediamine) platin II in cisplatin-sensitive and resistant human ovarian carcinoma cells. Cancer Research, 54, 2680-2687.
33. JORRITSMA, J. B. M., BURGMAN, P., KAMPINGA, H. H., and KONINGS, A. W. T., 1986, DNA polymerase activity in heat killing and hyperthermic radiosensitization of mammalian cells as observed after fractionated heat treatments. Radiation Research, 105, 307-319.
34. KONINGS, A. W. T., HETTINGA, J. V. E., LEMSTRA, W., HUMPHREY, G. B., and KAPINGA, H. H., 1993, Sensitizing for cisplatin action by hyperthermia in resistant cells. International Journal of Hyperthermia, 9, 553-562.
35. KUBOTA, N., KAKEHI, M., INADA, T., 1993, Hyperthermic enhancement of cell killing by five platinum complexes in human malignant melanoma cells grown as monolayer cultures and multicellular spheroids. International Journal of Radiation Oncology, 25, 491-497.
36. KUSKE, R. R., PEREZ, C. A., GRIGSBY, P. W., LOVETT, R. D., JACOBS, A. J., GALAKATOS, A. E., CAMEL, H. M., and KAO, M. S., 1989, Phase I/II study of definitive radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) for advanced or recurrent gynecologic malignancies. American Journal of Clinical Oncology, 12, 467-473.
37. LI., G. C., EVANS, R. G., and HAHN, G. M., 1976, Modification and inhibition of repair of potentially-lethal X-ray damage by hyperthermia. Radiation Research, 67, 491-501.
38. MASUDA, H., OZOLS, R. F., LAI, G. M., FOJO, A., ROTHENBERG, M., and HAMILTON, T. C., 1988, Increased DNA repair as a mechanism of acquired resistance to cis-diaminedichloroplatinum II in human ovarian cancer cell lines. Cancer Research, 48, 5713-5716.
39. MEUER, C., MULDER, N. H., HOSPERS, G. A. P., UGES, D. R. A., and DE VRIES, E. G. E., 1990, The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line. British Journal of Cancer, 62, 72-77.
40. MICETICH, K., ZWELLING, L., KOHN, K. W., 1983, Quenching of DNA: platinum (II) monoadducts as a possible mechanism of resistance to cis-diaminedichloroplatinum (II) in L1210 cells. Cancer Research, 43, 3609-3613.
41. MIVECHI, N., and DEWEY, W. C., 1984, Effect of glycerol and low pH on heat-induced cell killing and loss of cellular DNA polymerase activities in Chinese hamster ovary cells. Radiation Research. 99, 352-362.
42. MIYAHARA, T., UEDA, K., AKABOSHI, M., SHIMADA, Y., IMAMURA, M., and UTSUMI, H., 1993, Hyperthermic enhancement of cytotoxicity and increased uptake of cis-diaminedichloroplatinum (II) in cultured human esophageal cancer cells. Japan Journal of Cancer Research, 84, 336-346.
43. NIAS, A. H. W., 1985, Radiation and platinum drug interaction. International Journal of Radiation Biology, 48, 297-314.
44. OSHITA, F., FUJIWARA, Y., SAIGO, N., 1992, Radiation sensitivities in various anticancer drug resistant human lung cancer cell lines and mechanism of radiation cross-resistance in a cisplatin-resistant cell line. Journal of Cancer Research & Clinical Oncology, 119, 28-34.
45. PIVER, M. S., 1984, Ovarian carcinoma, a decade of progress. Cancer, 54, 2706-2715.
46. RAAPHORST, G. P., FREEMAN, M. L., and Dewey, W. C., 1979, Radiosensitivity and recovery from radiation damage in cultured CHO cells exposed to hyperthermia at 42.5 and 45.5°C. Radiation Research, 79, 390-402.
47. RAAPHORST, G. P., 1989, Thermal radiosensitization in vitro. Hyperthermia and Oncology. Vol. 2. Edited by M. Urano and E. Douple (Utrecht, VSP) pp. 17-51.
48. RAAPHORST, G. P., 1992, Recovery of sublethal radiation damage and its inhibition by hyperthermia in normal and transformed mouse cells. International Journal of Radiation Oncology, 22, 1035-1041.
49. RAAPHORST, G. P. FEELEY, M. M., CHU, G. L., and DEWEY, W. C., 1993a, A comparison of hyperthermia enhancement of radiation sensitivity and DNA polymerase inactivation in human glioma cells. Radiation Research, 137, 338-345.
50. RAAPHORST, G. P., MAO, J. P., and NG, C. E., 1993b, Repair of potentially-lethal damage: its inhibition by hyperthermia in two melanoma cell lines with different radio- and heat sensitivities. Melanoma Research, 3, 351-356.
51. RAAPHORST, G. P., BUSSEY, A., HELLER, D. P., and NG, C. E., 1994a, Comparison of thermoradiosensitization in two human melanoma cell lines and one fibroblast cell line by concurrent mild hyperthermia and low-dose-rate irradiation. Radiation Research, 137, 338-345.
52. RAAPHORST, G. P. MAO, J. P., and NG, C. E., 1994b, Sublethal radiation damage repair and its inhibition by hyperthermia in two human melanoma cell lines of different radiosensitivity. Melanoma Research, 4, 157-161.
53. RAAPHORST, G. P., DOJA, S., DAVIS, L., STEWART, D., and NG, C. E., 1995a, Comparison of cisplatin-hyperthermia sensitization in human ovarian carcinoma and glioma cell lines sensitive and resistant to cisplatin treatment. Cancer Chemother Pharmacology, 37, 574-580.
54. RAAPHORST, G. P., WANG, G., and NG, C. E., 1995b, Radiosensitization by cisplatin treatment in cisplatin-resistant and sensitive human ovarian carcinoma cell lines. International Journal of Oncology, 7, 325-330.
55. RAAPHORST, G. P., YANG, D. P., GREWAAL, D., STEWART, D., GOEL, R., and NG, C. E., 1995c, Analysis of mechanisms of cisplatin resistance in three pairs of human tumour cell lines expressing normal and resistant responses to cisplatin. Oncology Reports, 2, 1037-1043.
56. RAAPHORST, G. P., WANG, G., STEWART, D. J., and NG, C. E., 1996, Concomitant low dose-rate irradiation and cisplatin treatment in ovarian carcinoma cell lines sensitive and resistant to cisplatin treatment. International Journal of Radiation Biology (in press).
57. RAAPHORST, G. P., and FEELEY, M. M., 1994, Comparison of post hyperthermia radiosensitivity for survival, PLDR and polymerase activity in human glioma cells. International Journal of Radiation Oncology, 29, 133-139.
58. SCHWACHOFER, J. H. M., CROOIJMANS, R. P. M. A., HOOGENHOUT, J., KAL, H. B., and THEEUWES, A. G. M., 1991, Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin influence of treatment sequence. International Journal of Radiation Oncology. 20, 1235-1241.
59. SLEDGE, G. W., 1992, Cisplatin and platinum analogues in breast cancer. Seminars in Oncology. 19, 78-82.
60. SUPI, G., BADARACCO, G., CAVATIERE, R., NATALI, F. G., and GERCO, C., 1994, Influence of sequence on hyperthermia and drug combination. Hyperthermic Oncology, 1, 429-431.
61. SZUMIEL, I., and NIAS, A. H. W., 1976, The effect of combined treatment with a platinum complex and ionizing radiation of Chinese hamster ovary cells in vitro. British Journal of Cancer, 33, 450-458.
62. TAYLOR, S. G., MURPHY, A. K., VANNETZEL, J. M., COLIN, P., DROY, M., CALDERELLI, D. D., SHOLT, S., YOKES, E., SHOWEL, J. L., HUCHISON, J. C., WITT, T. R., GRIEM, K. L., HARTSELL, W. F., KIES, M. S., MITTAL, B., REBISCHUNG, J. L., COUPEZ, D. J., DESPHIEUX, J. L. ROBIN, S., and LEPAJOLEC, C., 1994, Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. Journal of Clinical Oncology, 12, 385-395.
63. URANO, M., KAHN, J., and KENTON, L. A., 1990, The effect of cisplatin I treatment at elevated temperatures on murine fibrosarcoma. F.Sa-II. International Journal of Hyperthermia, 6, 563-570.
64. WALLNER, K. E., and LI, G. C., 1987, Effect of cisplatin resistance on cellular radiation response. International Journal of Radiation Oncology, 13, 587-591.
65. WALTER, P., KORBELIK, M., SPADINGER, I., and SKOV, K., 1993, Investigations into mechanisms of the interaction between platinum complexes and irradiation at low (2 Gy) doses in hypoxic cells: role of single strand breaks. Radiation Oncology Investigations, 1, 137-147.
66. WANG, Z., ARMOUR, E. P., CORRY, P. M., and MARTINEZ, A., 1992, Elimination of dose-rate effects by mild hyperthermia. International Journal of Radiation Oncology, Biology and Physics, 24, 965-973.
67. WILKINS, D. E., NG, C. E., and RAAPHORST, G. P., 1996, Cisplatin and low dose-rate irradiation in cisplatin-resistant and sensitive human glioma cells. International Journal of Radiation Oncology (in press).
68. WONDERGEM, J., SIDDIK, Z. H., STREBEL, F. R., and BULL, J. M. C., 1993, Effect of whole body hyperthermia on cis-diaminedichloroplatinum (II)-induced antitumour activity and tissue Pt-distribution. Do anaesthetics influence the therapeutic ratio? European Journal of Cancer 29a, 549-554.
69. ZIETMAN, A. L., SHIPLEY, W. U., and KAUFMAN, D. S., 1993, The combination of cisplatin based chemotherapy and radiation in the treatment of muscle-invading transitional cell cancer of the bladder. International Journal of Radiation Oncology, 27, 161-170.